Overview

Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of Two Single MT 400 or Naproxen Sodium Tablets

Status:
Completed

Trial end date:
2007-12-01

Target enrollment:

Participant gender:

Summary

This is an open-label, parallel group, single-center study. The study design consists of a screening and a treatment period. A total of 42 (approximately 21 of each sex) non-smoking healthy volunteers aged 18 - 35.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline

Collaborator:

POZEN

Treatments:

Naproxen